On October 26, 2020 RhoVac AB ("RhoVac") reported that it is participating this week in the partnering event BIO Europe 2020 Digital (Press release, RhoVac, OCT 26, 2020, View Source [SID1234569082]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This week the digital version of the massive pharmaceutical partnering conference BIO Europe is held with participation from RhoVac. The program features plenum sessions on contemporary common interest topics in the industry, but the emphasis is on partnering.

RhoVac’s CEO, Anders Månsson, comments: "RhoVac certainly maintains a regular dialogue with its potential partners also outside of digital congresses, but digital conferences like BIO Europe obviously provides us with an opportunity to `mass market’ our company and the RV001, and there is certainly a great interest out there."